The effects of p53 inhibition using pifithrin-α on acute necrotizing pancreatitis in rats;Pifithrin-α ile oluşturulan p53 inhibisyonunun sıçanlarda akut nekrotizan pankreatite etkileri

Turkish Journal of Medical Sciences

Volumn 41, Issue 4, 2011, Pages 673-683

  Alhan, Etem ^a   Cinel, Akif ^a   Erçin, Mehmet Cengiz ^b   Türkyilmaz, Serdar ^a   Vanizor Kural, Birgül ^a   Alper, Murat ^c   Filinte, Deniz ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c Dişkapi Education and Research Hospital ^*  (Turkey)

Author keywords

Acute pancreatitis; P53; Pifithrin

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; CALCIUM; GLYCODEOXYCHOLIC ACID; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MALONALDEHYDE; MYELOPEROXIDASE; OXYGEN; PIFITHRIN ALPHA; PROTEIN P53; SODIUM CHLORIDE; UREA;

ACINAR CELL; ACUTE HEMORRHAGIC PANCREATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CAPILLARY DENSITY; CARDIOPULMONARY FUNCTION; CELL DAMAGE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MORTALITY; NONHUMAN; OXYGEN TENSION; PANCREAS NECROSIS; PROTEIN SYNTHESIS INHIBITION; RAT; SHAM PROCEDURE; UREA BLOOD LEVEL; URINE VOLUME;

EID: 79960826259     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1007-984     Document Type: Article

References (39)

1. Schwarz M, Thomson J, Meyer H, Büchler MW, Beger HG. Frequency and time course of pancreatic and extra pancreatic bacterial infection in experimental pancreatitis in rats. Surgery 2000; 127: 427-32.
2. Saluja AK, Steer ML. Pathophysiology of pancreatitis. Role of cytokines and inflammatory mediators. Digestion 1999; 60 (Suppl 1): 27-33.
3. Klar E, Messmer K, Warshaw, Herfarth C. Pancreatic ischemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg 1990; 77: 1205-10.
4. Alhan E, Kücüktülü U, Erçin C, Deger O, Çicek R. The effects of dopexamine on acute necrotizing pancreatitis in rats. Eur J Surg 2001; 167: 761-66.
5. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998; 1175: 76-83.
6. Alhan E, Kalyoncu NI, BV Kural, Erçin C. Effects of melatonin on acute pancreatitis in rats. Z Gastroenterol 2004; 42: 967-72.
7. Beger HG, Bittner R, Büchler M. Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology 1986; 90: 74-9.
8. Banks PA, Tenner S, Noordhoek EC, Sica G, Feng S, Zinner M. Does pancreatic necrosis predict severity in patients with acute necrotizing pancreatitis? Digestion 1996; 57: 218-23.
9. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P et al. Pathophysiology of acute pancreatitis. Pancreatology 2005; 5: 132-34.
10. Chinaiyan AM, Teper CG, Seldin MF. FADD/Mort1 is a common mediator of CD95 (Fas/APO1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996; 271: 4961-65.
11. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter M. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254: 439-59.
12. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15: 2922-33.
13. Nagata S. Fas ligand induced apoptosis. Annu Rev Genet 1999; 33: 29-55.
14. Riedl SJ, Shi Y. Molecular mechanism of caspase regulation during apoptosis. Mol Cell Biol 2004; 5: 897-907.
15. Kim AL, Raffo AJ, Brand-Rauf PW, Pincus MR, Monaco R, Abarzua P et al. Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells. J Biol Chem 1999; 274: 34924-31.
16. Yuan J, Murrell GA, Trickett A, Wang MX. Involvement of cytochrome c release and caspase-3 activation in the oxidative stress-induced apoptosis in human tendon fibroblasts. Biochim Biophys Acta. 2003; 1641: 35-41.
17. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3: 221-27.
18. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22: 8590-607.
19. Beil M, Leser J, Lutz MP, Gukovskaya A, Seuferlein T, Lynch G et al. Caspase 8-mediated cleavage of plectin precedes F-actin breakdown in acinar cells during pancreatitis. Am J Physiol Gastrointest Liver Physiol 2002; 282: G450-60.
20. Song SJ, Lim JW, Kim H, Morio T, Kim KH. Oxidative stress induces nuclear loss of DNA repair proteins Ku 70 and Ku 80 and apoptosis in pancreatic acinar AR42J cells. J Biol Chem 2003; 278: 36676-87.
21. Gomez G, Lee HM, He Q, Englander EW, Uchida T, Greeley GH Jr. Acute pancreatitis signals activation of apoptosisassociated and survival genes in mice. Exp Biol Med 2001; 226: 692-700.
22. Masamune A, Sakai Y, Yoshida M, Satoh A, Satoh K, Shimosegawa T. Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells. Dig Dis Sci 2001; 46: 1871-81.
23. Sandoval D, Gukovskaya A, Reavey P, Gukovsky S, Sisk A, Braquet P et al. The role of neutrophils and plateletactivating factor in mediating experimental pancreatitis. Gastroenterology 1996; 111: 1081-91.
24. Malka D, Vasseur S, Bödeker H, Ortiz EM, Dusetti NJ, Verrando P et al. Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology 2000; 119: 816-28.
25. Sheikh MS, Fornace AJ. Role of p53 family members in apoptosis. J Cell Physiol 2000; 182: 171-81.
26. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. A chemical inhibitor of p53 that protects mice from side effects of cancer therapy. Science 1999; 285: 1733-37.
27. Schafer T, Scheuer C, Roenerk K, Menger MD, Vollmar B. Inhibition of p53 protects liver tissue against endotoxininduced apoptotic and necrotic cell death. FASEB J 2003; 17: 660-67.
28. Schmidt J, Rattner MD, Lewandrowski K. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215: 44-56.
29. Dobschuetz E, Biberthaler P, Mussack T, Langer S, Messmer K, Hoffmann T. Noninvasive in vivo assessment of the pancreatic microcirculation: orthogonal polarization spectral imaging. Pancreas 2003; 26: 139-43.
30. Sookhal S, Wang JJ, McCourt M, Kwan W, Bouchier DH, Redmond P. A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo. Ann Surg 2002; 235: 283-91.
31. Lankisch PG, Pohl U, Otto J, Rahlf G. When should treatment of acute experimental pancreatitis be started? The early phase of bile-induced acute pancreatitis. Res Exp Med 1988; 188: 123-29.
32. Bernstorff WV, Glickman JN, Odze RD, Farraye FA, Joo HG, Goedegebuure PS, Eberlein TJ. Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer 2002; 94: 2552-2560.
33. Shibakita M, Tachibana M, Dhar DK, Ohno S, Kubota H, Yoshimura H et al. Spontaneous apoptosis in advanced esophageal carcinoma: its relation to Fas expression. Clin Cancer Res. 2000; 6: 4755-59.
34. Liu P, Xu B, Cavalieri TA, Hock CE. Inhibition of p53 by pifithrin-alpha reduces myocyte apoptosis and leukocyte transmigration in aged rat hearts following 24 hours of reperfusion. Shock 2008; 30: 545-51.
35. Bhatia M. Apoptosis of pancreatic acinar cells in acute pancreatitis: is it good or bad? J Cell Mol Med 2004; 8: 402-9.
36. Yuan Y, Gong Z, Lou K, Tu S, Di Z, Xu J. Effect and mechanism of somatostatin analog on apoptosis of pancreatic acinar cells in acute pancreatitis in mice. Gastroenterol Hepatol 2001; 16: 683-88.
37. Murakami H, Nakao A, Kishimoto W, Nakano M, Takagel H. Detection of O2 - generation and neutrophil accumulation in rat lungs aft er acute necrotizing pancreatitis. Surgery 1995; 118: 547-54.
38. Weidenhach H, Lerch MM, Gress TM, Pfaff D, Turi S, Adler G. Vasoactive mediators and the progression from edematous to necrotizing experimental acute pancreatitis. Gut 1995; 37: 434-40.
39. Borgström A, Appelros S, Müller CA, Uhl W, Büchler MW. Role of activation peptides from pancreatic proenzymes in the diagnosis and prognosis of acute pancreatitis. Surgery 2002; 131: 125-28.